The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas

被引:5
|
作者
Alonso-Juarranz, Miguel [1 ,2 ]
Mascaraque, Marta [3 ,4 ]
Carrasco, Elisa [3 ,5 ]
Gracia-Cazana, Tamara [6 ]
De La Sen, Oscar [1 ,2 ]
Gilaberte, Yolanda [6 ]
Gonzalez, Salvador [5 ,7 ]
Juarranz, Angeles [3 ,5 ]
Falahat, Farzin [1 ,2 ]
机构
[1] Hosp Clin San Carlos, Oral & Maxillofacial Surg Serv, Madrid 28040, Spain
[2] Univ Complutense, Fac Med, Surg Dept, Madrid 28040, Spain
[3] Univ Autonoma Madrid, Dept Biol, Madrid 28049, Spain
[4] Miguel Servet Univ Hosp, Translat Res Unit, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[5] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Dept Expt Dermatol & Skin Biol, Madrid 28034, Spain
[6] Miguel Servet Univ Hosp, Dept Dermatol, Inst Invest Sanitaria Aragon IIS, Zaragoza 50009, Spain
[7] Univ Alcala, Dept Med & Med Specialties, Madrid 28871, Spain
关键词
oral squamous cell carcinoma; cutaneous squamous cell carcinoma; tumor microenvironment; cancer-associated fibroblasts; immune cells; tertiary lymphoid structures; EPITHELIAL-MESENCHYMAL TRANSITION; GENOMIC CHARACTERIZATION; FIBROBLAST ACTIVATION; CANCER; HEAD; RISK; PROGRESSION; INVASION; THERAPY; MACROPHAGES;
D O I
10.3390/cancers15123227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In this review, we describe the recent studies that define the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively). Mutations in tumor suppressor genes and protooncogenes cooperate in determining the differentiation, aggressiveness, and metastatic potential of these types of cancers. Driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. We also describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes have been more frequently reported as predictors of good responses in OSCC than CSCC. Squamous cell carcinomas arise from stratified squamous epithelia. Here, a comparative analysis based on recent studies defining the genetic alterations and composition of the stroma of oral and cutaneous squamous cell carcinomas (OSCC and CSCC, respectively) was performed. Both carcinomas share some but not all histological and genetic features. This review was focused on how mutations in tumor suppressor genes and protooncogenes cooperate to determine the differentiation, aggressiveness, and metastatic potential of OSCC and CSCC. In fact, driver mutations in tumor suppressor genes are more frequently observed in OSCC than CSCC. These include mutations in TP53 (encoding pP53 protein), CDKN2A (encoding cyclin dependent kinase inhibitor 2A), FAT1 (encoding FAT atypical cadherin 1), and KMT2D (encoding lysine methyltransferase 2D), with the exception of NOTCH (encoding Notch receptor 1), whose mutation frequency is lower in OSCC compared to CSCC. Finally, we describe the differential composition of the tumor microenvironment and how this influences the aggressiveness of each tumor type. Although both OSCC and CSCC tumors are highly infiltrated by immune cells, high levels of tumor-infiltrating lymphocytes (TILs) have been more frequently reported as predictors of better outcomes in OSCC than CSCC. In conclusion, OSCC and CSCC partially share genetic alterations and possess different causal factors triggering their development. The tumor microenvironment plays a key role determining the outcome of the disease.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas
    Fundyler, O
    Khanna, M
    Smoller, BR
    MODERN PATHOLOGY, 2004, 17 (05) : 496 - 502
  • [2] Galectin 3 expression in primary oral squamous cell carcinomas
    Weber, Manuel
    Buettner-Herold, Maike
    Distel, Luitpold
    Ries, Jutta
    Moebius, Patrick
    Preidl, Raimund
    Geppert, Carol I.
    Neukam, Friedrich W.
    Wehrhan, Falk
    BMC CANCER, 2017, 17
  • [3] The impact of propranolol on apoptosis in cutaneous squamous cell carcinomas
    Celik, E.
    Kaplan, H. M.
    Singirik, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (11): : 801 - 804
  • [4] The prognostic significance of tertiary lymphoid structures in oral squamous cell carcinomas: a systematic review
    Ribeiro, V.
    Teillaud, J-L
    Dieu-Nosjean, M-C
    Lescaille, G.
    Rochefort, J.
    FRONTIERS IN ORAL HEALTH, 2025, 5
  • [5] Role of immunohistochemistry in the diagnosis and staging of cutaneous squamous-cell carcinomas (Review)
    Balasescu, Elena
    Gheorghe, Andreea-Cristina
    Moroianu, Andreea
    Turcu, Gabriela
    Brinzea, Alice
    Antohe, Mihaela
    Hodorogea, Anastasia
    Manea, Lorena
    Balaban, Mihaela
    Andrei, Razvan
    Hulea, Ionela
    Popp, Cristiana Gabriela
    Nichita, Luciana
    Cioplea, Mirela Daniela
    Zurac, Sabina Andrada
    Ion, Daniela Adriana
    Nedelcu, Roxana Ioana
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (06)
  • [6] Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion
    Kus, Kylee J. B.
    Murad, Fadi
    Smile, Timothy D.
    Chang, Michael
    Ashrafzadeh, Sepideh
    Zhou, Guohai
    Ilori, Evelyn O.
    Koyfman, Shlomo A.
    Vidimos, Allison T.
    Schmults, Chrysalyne D.
    Ruiz, Emily S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (04) : 766 - 773
  • [7] Small and Thin Oral Squamous Cell Carcinomas may Exhibit Adverse Pathologic Prognostic Features
    Mohammed Nur, Mutaz
    Al Saadi, Maimuna
    O'Regan, Esther M.
    Van Harten, Maria
    Toner, Mary
    HEAD & NECK PATHOLOGY, 2021, 15 (02) : 461 - 468
  • [8] Predictive Factors in the Appearance and Evolution of Squamous Cell Carcinomas of the Oral Cavity
    Carp, Alexandra
    Nicolau, Andrei
    Moscalu, Mihaela
    Popescu, Eugenia
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [9] Oral squamous cell carcinomas and oral potentially malignant disorders: A Latin American study
    Gilligan, Gerardo
    Panico, Rene
    Lazos, Jeronimo
    Morelatto, Rosana
    Belardinelli, Paola
    Criscuolo, Ines
    Bolesina, Nicolas
    Avila, Ignacio Molina
    Sola, Juan Martin Pimentel
    Rivarola, Emilce
    Morgante, Maria Jimena
    Tonelli, Maria Eugenia Ingrassia
    Gimenez, Javier
    Doratti, Pablo
    Werner, Laura Cecilia
    Prado-Ribeiro, Ana Carolina
    Brandao, Thais Bianca
    Vechiato-Filho, Aljomar Jose
    Cuzzullin, Maria Claudia
    Saldivia-Siracusa, Cristina
    Lopes, Marcio Ajudarte
    Agostini, Michelle
    Romanach, Mario Jose
    Abrahao, Aline Correa
    Fonseca, Thamyres Campos
    Kaminagakura, Estela
    Anbinder, Ana Lia
    Alves, Kamilla Santos
    Lanca, Maria Leticia de Almeida
    Sacsaquispe-Contreras, Sonia
    Ibazetta, Karem Rodriguez
    Gerber-Mora, Roberto
    Romo, Saray Aranda
    Nava, Francisco Javier Tejeda
    Cordero-Torres, Karina
    Silva, Ricardo Moreno
    Gonzalez-Arriagada, Wilfredo
    Toro, Raiza
    Silveira, Felipe Martins
    Gonzalez, Natalia
    Vargas, Pablo Agustin
    Santos-Silva, Alan Roger
    Bologna-Molina, Ronell
    Villarroel-Dorrego, Mariana
    Martinez, Benjamin
    Piemonte, Eduardo
    ORAL DISEASES, 2024, 30 (05) : 2965 - 2984
  • [10] MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas
    Omar, Abdirisak Ahmed Haji
    Haglund, Caj
    Virolainen, Susanna
    Hayry, Valtteri
    Atula, Timo
    Kontio, Risto
    Salo, Tuula
    Sorsa, Timo
    Hagstrom, Jaana
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2015, 119 (04): : 459 - 467